IMMUNE PHARMACEUTICALS INC 4
4 · IMMUNE PHARMACEUTICALS INC · Filed Jan 23, 2015
Insider Transaction Report
Form 4
Berdugo Gad
Director
Transactions
- Award
Stock Option
2015-01-22+370,000→ 370,000 totalExercise: $1.92Exp: 2025-01-22→ Common Stock (370,000 underlying)
Footnotes (2)
- [F1]The stock options shall vest over a three-year period, with 1/3 of the stock options granted vesting annually commencing on January 22, 2016.
- [F2]These securities were issued pursuant to an employment agreement, dated January 21, 2015, entered into between the Issuer and the Reporting Person in connection with the appointment of the Reporting Person as Executive Vice President and Chief Financial Officer of the Issuer, effective January 22, 2015.